{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:29:51Z","timestamp":1790616591346,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.mce.2004.03.004","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T17:36:16Z","timestamp":1085852176000},"page":"109-123","source":"Crossref","is-referenced-by-count":55,"title":["Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells"],"prefix":"10.1016","volume":"220","author":[{"given":"Esther","family":"Weiss-Messer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osnat","family":"Merom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayala","family":"Adi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Karry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maslama","family":"Bidosee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie","family":"Ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kaploun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie J","family":"Barkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2004.03.004_BIB1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0303-7207(94)90216-X","article-title":"The Hep G2 cell line in the study of growth hormone receptor\/binding protein","volume":"101","author":"Amit","year":"1994","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2004.03.004_BIB2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1677\/joe.0.1690397","article-title":"Shedding of growth hormone-binding protein is inhibited by hydroxamic acid-based protease inhibitors: proposed mechanism of activation of growth hormone-binding protein secretase","volume":"169","author":"Amit","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.mce.2004.03.004_BIB3","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1210\/jc.82.11.3813","article-title":"A membrane-fixed truncated isoform of the human growth hormone receptor","volume":"82","author":"Amit","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2004.03.004_BIB4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0092-8674(93)90415-M","article-title":"Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase","volume":"74","author":"Argetsinger","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.mce.2004.03.004_BIB5","first-page":"1981","article-title":"Constitutive activation of the Ras\/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells","volume":"63","author":"Bakin","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2004.03.004_BIB6","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1210\/jc.85.8.2865","article-title":"Distribution and abundance of messenger ribonucleic acid for growth hormone receptor isoforms in human tissues","volume":"85","author":"Ballesteros","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2004.03.004_BIB7","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1210\/endo-115-5-1805","article-title":"Monoclonal antibodies to the rabbit liver growth hormone receptor: production and characterization","volume":"115","author":"Barnard","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2004.03.004_BIB8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/bj2310459","article-title":"Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor","volume":"231","author":"Barnard","year":"1985","journal-title":"Biochem. J."},{"key":"10.1016\/j.mce.2004.03.004_BIB9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.mce.2004.03.004_BIB10","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1016\/S0021-9258(18)42663-4","article-title":"Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts","volume":"267","author":"Campbell","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2004.03.004_BIB11","first-page":"61","article-title":"Signaling via JAK tyrosine kinases: growth hormone receptor as a model system","volume":"53","author":"Carter-Su","year":"1998","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.mce.2004.03.004_BIB12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1054\/ghir.2002.0271","article-title":"Co-expression of GH and GHR isoforms in prostate cancer cell lines","volume":"12","author":"Chopin","year":"2002","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.mce.2004.03.004_BIB13","doi-asserted-by":"crossref","first-page":"17499","DOI":"10.1074\/jbc.274.25.17499","article-title":"Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone","volume":"274","author":"Costello","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2004.03.004_BIB14","first-page":"5474","article-title":"Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor","volume":"54","author":"Culig","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2004.03.004_BIB15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0303-7207(02)00263-0","article-title":"Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth","volume":"197","author":"Culig","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2004.03.004_BIB16","doi-asserted-by":"crossref","first-page":"10723","DOI":"10.1073\/pnas.93.20.10723","article-title":"Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein","volume":"93","author":"Dastot","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2004.03.004_BIB17","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/sj.onc.1202251","article-title":"Signaling by dual specificity kinases","volume":"17","author":"Dhanasekaran","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2004.03.004_BIB18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/(SICI)1097-0045(19980515)35:3<212::AID-PROS7>3.0.CO;2-I","article-title":"Coexpression of gonadotropic hormones and their corresponding FSH- and LH\/CG-receptors in the human prostate","volume":"35","author":"Dirnhofer","year":"1998","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2004.03.004_BIB19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1097-0045(20000201)42:2<150::AID-PROS10>3.0.CO;2-H","article-title":"Dysregulated expression of growth factors and their receptors in the development of prostate cancer","volume":"42","author":"Djakiew","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2004.03.004_BIB20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000049782","article-title":"Molecular biology of the androgen receptor: from molecular understanding to the clinic","volume":"40","author":"Eder","year":"2001","journal-title":"Eur. Urol."},{"issue":"Suppl. A","key":"10.1016\/j.mce.2004.03.004_BIB21","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/S1096-6374(01)80020-4","article-title":"Cancer and the potential place for growth hormone receptor antagonist therapy","volume":"11","author":"Friend","year":"2001","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.mce.2004.03.004_BIB22","doi-asserted-by":"crossref","first-page":"24500","DOI":"10.1074\/jbc.M003145200","article-title":"Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression","volume":"275","author":"Graff","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2004.03.004_BIB23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/pros.2990240502","article-title":"A serum-free defined medium capable of supporting growth of four established human prostatic carcinoma cell lines","volume":"24","author":"Hedlund","year":"1994","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2004.03.004_BIB24","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1172\/JCI112507","article-title":"Identification and characterization of specific binding proteins for growth hormone in normal human sera","volume":"77","author":"Herington","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2004.03.004_BIB25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1043-2760(01)00423-4","article-title":"Signaling pathways activated by the growth hormone receptor","volume":"12","author":"Herrington","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.mce.2004.03.004_BIB26","first-page":"3068","article-title":"Distant metastases from prostatic carcinoma express androgen receptor protein","volume":"55","author":"Hobisch","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2004.03.004_BIB27","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/endo-127-4-1665","article-title":"Human liver growth hormone receptor and plasma binding protein: characterization and partial purification","volume":"127","author":"Hocquette","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2004.03.004_BIB28","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1210\/endo-125-4-2167","article-title":"The human liver growth hormone receptor","volume":"125","author":"Hocquette","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2004.03.004_BIB29","doi-asserted-by":"crossref","first-page":"31327","DOI":"10.1074\/jbc.273.47.31327","article-title":"Growth hormone stimulates phosphorylation and activation of Elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2","volume":"273","author":"Hodge","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2004.03.004_BIB30","first-page":"1809","article-title":"LNCaP model of human prostatic carcinoma","volume":"43","author":"Horoszewicz","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2004.03.004_BIB31","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1210\/endo-112-6-1980","article-title":"Analysis of growth hormone and lactogenic binding sites cross-linked to iodinated human growth hormone","volume":"112","author":"Hughes","year":"1983","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2004.03.004_BIB32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-9525(00)89000-9","article-title":"Jaks and Stats in signaling by the cytokine receptor superfamily","volume":"11","author":"Ihle","year":"1995","journal-title":"Trends Genet."},{"key":"10.1016\/j.mce.2004.03.004_BIB33","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1210\/en.130.4.2037","article-title":"Cellular processing of growth hormone in IM-9 cells: evidence for exocytosis of internalized hormone","volume":"130","author":"Ilondo","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2004.03.004_BIB34","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1073\/pnas.85.3.890","article-title":"Receptors for prolactin, somatostatin, and luteinizing hormone-re leasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin","volume":"85","author":"Kadar","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mce.2004.03.004_BIB35","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1210\/en.142.2.767","article-title":"The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor","volume":"142","author":"Kaulsay","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2004.03.004_BIB36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1210\/edrv-12-3-235","article-title":"The prolactin\/growth hormone receptor family","volume":"12","author":"Kelly","year":"1991","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2004.03.004_BIB37","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0021-9258(18)48380-9","article-title":"Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones","volume":"267","author":"Kemppainen","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2004.03.004_BIB38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(02)00398-0","article-title":"Signaling through the JAK\/STAT pathway, recent advances and future challenges","volume":"285","author":"Kisseleva","year":"2002","journal-title":"Gene."},{"key":"10.1016\/j.mce.2004.03.004_BIB39","first-page":"911","article-title":"Expression of growth hormone receptor in human prostatic carcinoma and hyperplasia","volume":"14","author":"Kolle","year":"1999","journal-title":"Int. J Oncol."},{"key":"10.1016\/j.mce.2004.03.004_BIB40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/330537a0","article-title":"Growth hormone receptor and serum binding protein: purification, cloning and expression","volume":"330","author":"Leung","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.mce.2004.03.004_BIB41","first-page":"2891","article-title":"The phosphatidylinositol 3\u2032-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells","volume":"59","author":"Lin","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2004.03.004_BIB42","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1210\/en.139.4.1965","article-title":"Growth hormone stimulation of the mitogen-activated protein kinase pathway is cell type specific","volume":"139","author":"Love","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2004.03.004_BIB43","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/emboj\/17.7.2008","article-title":"Activation of the Src\/p21ras\/Erk pathway by progesterone receptor via cross-talk with estrogen receptor","volume":"17","author":"Migliaccio","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.mce.2004.03.004_BIB44","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1091\/mbc.9.9.2527","article-title":"Activation of Androgen Receptor Function by a Novel Nuclear Protein Kinase","volume":"9","author":"Moilanen","year":"1998","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.mce.2004.03.004_BIB45","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(18)50105-8","article-title":"Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA","volume":"267","author":"Moller","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2004.03.004_BIB46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1172\/JCI119204","article-title":"Prolactin and prolactin receptors are expressed and functioning in human prostate","volume":"99","author":"Nevalainen","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2004.03.004_BIB47","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1432-1033.1997.00615.x","article-title":"The structure","volume":"248","author":"Pellegrini","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.mce.2004.03.004_BIB48","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1038\/sj.onc.1203032","article-title":"Rapid signalling by androgen receptor in prostate cancer cells","volume":"18","author":"Peterziel","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2004.03.004_BIB49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0303-7207(92)90011-T","article-title":"Growth hormone and prolactin stimulate androgen receptor","volume":"88","author":"Reiter","year":"1992","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2004.03.004_BIB50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1097-0045(19990201)38:2<159::AID-PROS10>3.0.CO;2-5","article-title":"Effects of pituitary hormones on the prostate","volume":"38","author":"Reiter","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2004.03.004_BIB51","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1210\/en.136.8.3338","article-title":"Growth hormone directly affects the function of the different lobes of the rat prostate","volume":"136","author":"Reiter","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2004.03.004_BIB52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1210\/me.11.3.265","article-title":"A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein","volume":"11","author":"Ross","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2004.03.004_BIB53","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1210\/endo-121-4-1521","article-title":"Processing of growth hormone by rat adipocytes in primary culture: differentiation between release of intact hormone and degradative processing","volume":"121","author":"Roupas","year":"1987","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2004.03.004_BIB54","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1210\/en.140.5.1984","article-title":"Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development","volume":"140","author":"Ruan","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2004.03.004_BIB55","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/clinchem\/44.4.705","article-title":"Growth factor involvement in progression of prostate cancer","volume":"44","author":"Russell","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mce.2004.03.004_BIB56","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1002\/1097-0142(19910615)67:12<3057::AID-CNCR2820671221>3.0.CO;2-S","article-title":"Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy","volume":"67","author":"Sadi","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.mce.2004.03.004_BIB57","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1749-6632.1949.tb27297.x","article-title":"The attraction of proteins for small molecules and ions","volume":"51","author":"Scatchard","year":"1949","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.mce.2004.03.004_BIB58","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1210\/en.133.5.2307","article-title":"Human growth hormone (GH) receptor is characterized as the 134-kilodalton tyrosine-phosphorylated protein activated by GH treatment in IM-9 cells","volume":"133","author":"Silva","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2004.03.004_BIB59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/excr.2000.5130","article-title":"PTEN: life as a tumor suppressor","volume":"264","author":"Simpson","year":"2001","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.mce.2004.03.004_BIB60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0014-5793(93)80028-S","article-title":"Expression and binding properties of two isoforms of the human growth hormone receptor","volume":"319","author":"Sobrier","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mce.2004.03.004_BIB61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000480883","article-title":"Serum free total prostatic-specific antigen in prostate cancer patients treated with LH-RH agonists","volume":"32","author":"Stein","year":"1997","journal-title":"Eur. Urol."},{"key":"10.1016\/j.mce.2004.03.004_BIB62","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.86.8.3467","article-title":"The endocrinology of prostate cancer","volume":"86","author":"Taplin","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2004.03.004_BIB63","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/pros.10245","article-title":"ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002","volume":"56","author":"Torring","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2004.03.004_BIB64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0303-7207(99)00206-3","article-title":"Signaling mechanisms of cytokine receptors and their perturbances in disease","volume":"160","author":"Touw","year":"2000","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2004.03.004_BIB65","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0531-5565(98)00063-1","article-title":"Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors","volume":"34","author":"Untergasser","year":"1999","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.mce.2004.03.004_BIB66","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ijc.2910480206","article-title":"Androgen receptors in endocrine-therapy-resistant human prostate cancer","volume":"48","author":"Van der Kwast","year":"1991","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mce.2004.03.004_BIB67","first-page":"2720","article-title":"Frequent inactivation of PTEN in prostate cancer cell lines and xenografts","volume":"58","author":"Vlietstra","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2004.03.004_BIB68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1097-0045(19970101)30:1<58::AID-PROS9>3.0.CO;2-H","article-title":"Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. 2. Tumorigenic cell lines","volume":"30","author":"Webber","year":"1997","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2004.03.004_BIB69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0303-7207(98)00134-8","article-title":"Characterization and regulation of prolactin receptors in MA-10 Leydig cells","volume":"143","author":"Weiss-Messer","year":"1998","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2004.03.004_BIB70","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1016\/S0021-9258(18)42895-5","article-title":"Growth hormone stimulates the tyrosine phosphorylation of 42- and 45-kDa ERK-related proteins","volume":"267","author":"Winston","year":"1992","journal-title":"J. Biol. Chem."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720704001017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720704001017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T17:17:39Z","timestamp":1624382259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720704001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":70,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0303720704001017"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2004.03.004","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}